Increased Serum Level of MB Isoenzyme of Creatin Kinase out of the Context of Acute Myocardial Infarction;Elevação da isoenzima mb da creatinaquinase fora de um contexto de enfarte agudo do miocárdio

Acta Medica Portuguesa

Volumn 11, Issue 5, 1998, Pages 507-510

  Fonseca, J E ^a   Calado, Lisete ^a   Metrass, M José ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; ISOENZYME; TUMOR MARKER;

AGED; ARTICLE; BLOOD; BONE TUMOR; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ENZYME ASSAY; HEART INFARCTION; HUMAN; MALE; METASTASIS; PARANEOPLASTIC SYNDROME; PATHOLOGY; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE NEOPLASMS; CREATINE KINASE; DIAGNOSIS, DIFFERENTIAL; ENZYME TESTS; HUMANS; ISOENZYMES; MALE; MYOCARDIAL INFARCTION; PARANEOPLASTIC SYNDROMES; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032057357     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. DICKEY W, CARSON CA, ANDREWS WJ et al: Apparent elevation of serum CK-MB not due to acute myocardial infarction. Br J Clin Pract 46; 149-150, 1992
2. MARTINEZ-COMPADRE GJ, ORTEGA B, RUEDA-GUTIERREZ M: Can a prostatic adenocarcinoma simulate an acute myocardial infarction? Med Clin Bare 99: 538-540, 1992
3. LOTT JA, WOLF PL: Creatine kinase. In Clinical Enzymology: A case -oriented approach. New York, Field, Rich and Associates, 1986, p 149.
4. GAZDAR AF, ZWEIG MH, CARNEY DN et al: Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures. Cancer Res 41:2773-2777,1981
5. STORMONT TJ, FARROW GM, MYERS RP et al. Clinical stage BO or Tic prostate cancer nonpalpable disease identified by elevated serum prostate-specific antigen concentration. Urology 41:3-8, 1993
6. Cancer statistics 1994. CA Cancer J Clin 44: 7-26, 1994
7. PARTIN AW, YOO J, CARTER HB et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150:110-114, 1993
8. OESTERLING JE, MARTIN SK.BERGSTRALH EJ et al: The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA 269: 57-60, 1993
9. SZASZ G, GRUBER W, BERNT E. Clin Chem 22: 650, 1976
10. STEIN W. MED WELT 36: 572, 1985
11. LOTT JA, STANG JM: Differential diagnosis of patients with abnormal serum creatine kinase isoenzymes. Clinics in Laboratory Medicine 9: 627-642, 1989
12. JAQUES G, BEPLER G, HOLLE R et al: Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase and creatine kinase BB levels in sera of patients with small cell lung cancer. Cancer 6: 125-134, 1988
13. SCHWARTZ JG, BAZAN C, GAGE CL et al: Serum creatine kinase isoenzyme BB is a poor index to the size of various brain lesions. Clin Chem 35: 651-654, 1989
14. BACH F, BACH FW, PEDERSEN AG et al: Creatine kinase BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancer. Eur J Cancer Clin Oncol 25: 1703-1709, 1989
15. FUKODA J, YAGISHITA S, YAMAOKA K et al: Creatine kinase isoenzyme BB increased in serum and tumor tissue of patients with giant cell tumor of bone. Clin Chem 40: 2064-2065, 1994
16. ROGULJIC A, SAFWAN T, SEPAROVIC V: Creatine kinase BB activity in malignant tumors and in sera from patients with malignant diseases. Tumori 75. 537-541, 1989
17. SCARAZATTI E, LINO S, MARTINOLI F et al: Isoenzymes of creatine kinase and prostate specific antigen in the monitoring of prostatic carcinoma. Boll Soc Ital Biol Sper 66: 581-585, 1990